,

Learning from failure: congestive heart failure in the postgenomic age.

, и .
J. Clin. Invest., 115 (3): 495--499 (марта 2005)
DOI: 10.1172/JCI200524477

Аннотация

The prognosis of heart failure is worse than that of most cancers, but new therapeutic interventions using stem and other cell-based therapies are succeeding in the fight against it, and old drugs, with new twists, are making a comeback. Genetically engineered animal models are driving insights into the molecular mechanisms that cause hearts to fail, accelerating drug discoveries, and inspiring cell-based therapeutic interventions for both acquired and inheritable cardiac diseases.

тэги

Пользователи данного ресурса

  • @hake

Комментарии и рецензии